China Herb. Yindan Xintai Diwan for chest obstruction and coronary heart disease. Herbal Medicine. 200 pills*5 boxes

Yin Dan Xin Tai Di Wan
Yindan Xintai Diwan
Yin Dan Xin Tai Dripping Pills
Yindan Xintai Dripping Pills
Yindanxintai Diwan
Yindanxintai Dripping Pills

FUNCTION and INDICATIONS
For blood stasis induced chest apoplexy,chest obstruction,symptoms: chest tightness, chest pain, heart palpitations; coronary heart disease, angina are the syndromes.

Traditional Chinese Medicine Functions
Activating blood and dissolvng stasis,promoting coronary circulation and relieve pian.

INGREDIENTS
Ginkgo Leaf,Salvia yunnanensis,Fiveleaf Gynostemma Herb,Nature boreol.

DESCPRIPTION
This product is light brown or dark brown ball-shaped drop pills or film-coated pills, fragrance, taste slightly bitter.

SPECIFICATION AND PACKAGE
200 dripping pills/box.

USAGE AND DOSAGE
For oral use or Sub-lingual after meals,10 pills thrice daily ,four weeks a treatment course,or by medical ordor.

REFERENCES
Clinical Research:
In order to observe the clinical efficacy of Yin Dan Xin Tai Di Pill in the treatment of angina pectoris of coronary atherosclerotic heart disease, Zhang Dachuang and others used it to treat coronary atherosclerotic heart disease (referred to as coronary heart disease) and angina pectoris 40 Cases, and with isosorbide mononitrate treatment of 40 cases were observed. The same two groups of basic treatment. Forty patients in the treatment group were treated with Yindan Xintaidi Pill. In the control group, 40 patients were given isosorbide mononitrate tablets for 30 days for one course of treatment and after one course of treatment, the effect was statistically evaluated.
After the end of the course of treatment, the results of angina pectoris were as follows: The treatment group was markedly effective in 18 cases (45%), improvement in 20 cases (50%), ineffective in 2 cases (5%), and the total effective rate was 95%. The control group was markedly effective in 10 cases (25%), improvement in 18 cases (45%), ineffective in 12 cases (30%), the total effective rate was 70%. The total effective rate was significantly different between the two groups (P <0.05), the treatment group was better than the control group. Electrocardiogram ischemic efficacy results: The treatment group was significantly improved in 14 cases (35%), improvement of 16 (40%), no change in 10 cases (25%), the total effective rate of 75%. The control group markedly improved in 10 cases (25%), improved in 12 cases (30%), no change in 18 cases (45%), the total effective rate was 55%. The total effective rate was significantly different between the two groups (P <0.05), the treatment group was better than the control group. Hemorrheology was significantly improved in the treatment group with no significant change in the control group.

ADVERSE REACTION
Uncertainty.

CONTRAINDICATIONS
Uncertainty.

Warning
Uncertainty.

DRUG INTERACTION
If use with the other drugs at the same time may occur drug interactions,details please consult your physician or pharmacist.

STORAGE
Hermetically sealed,keep in cool and dry places.

PERIOD OF VALIDITY
30 months.

CERTIFICATE NO
Stage Food and Drug Administration Approval number:Z20025687.

Manufactured
GUIZHOU JUNZHITANG PHARMACEUTICAL CO.,LTD

Tips: Please read the directions for use in retail or directed by physician.
Part of the goods frequent replacement of packaging, such as goods and pictures are not exactly the same, please refer to the goods you receive.

General Cautions
Keep away from animals and children.This product has not been evaluated by the FDA. It is not intended to diagnose, treat, cure, or prevent any disease.We highly recommend that you consult with a Traditional Chinese Medical practitioner or physician before taking any products or if you have any questions regarding your health.